Findings

What do systematic reviews say?

46 questions · 46 findings · 24 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 42 · 91.3%GRADE not reported 3 · 6.5%Very low 0 · 0%Low 1 · 2.2%Moderate 0 · 0%High 0 · 0%

NSAIDs vs placebo

Health‐related quality of life: not measured№. of participants: 30 (1 RCT) · acute gout

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs for acute gout 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Bisphosphonates vs placebo

Number of participants with change in quality of life measures (not measured) · Paget's disease of bone

1 finding from 1 review

Bisphosphonates for Paget's disease of bone in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Proparacaine hydrochloride 0.5% eye drops vs placebo

Quality of life assessment 12 weeks after the start of treatment Not measured · patients with trigeminal neuralgia

The review found no eligible studies for this question.

1 finding from 1 review

Non‐antiepileptic drugs for trigeminal neuralgia 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Benzodiazepines vs phenobarbital (as active placebo)

Social confidence, social inclusion, social networks, or personalised quality of life ‐ not measured · patients with antipsychotic‐induced tardive dyskinesia

The review found no eligible studies for this question.

1 finding from 1 review

Benzodiazepines for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Dalteparin vs placebo

Quality of life (e.g. absence from school, lost time at work, mobility) as assessed by any validated questionnaire either generic or SCD specific) ‐ not measured · sickle cell disease

The review found no eligible studies for this question.

1 finding from 1 review

Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tinzaparin vs placebo

Quality of life (e.g. absence from school, lost time at work, mobility) as assessed by any validated questionnaire either generic or SCD specific) ‐ not measured · people with sickle cell disease

The review found no eligible studies for this question.

1 finding from 1 review

Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found